Herb–Drug Interactions Between Common Indonesian Medicinal Plants and Cardiovascular Medications: A Narrative Review
DOI:
https://doi.org/10.63142/jhsmbp.v1i2.263Keywords:
Cardiovascular drugs, Herb–drug interaction, Indonesian medicinal plants, Pharmacodynamics, PharmacokineticsAbstract
The simultaneous use of herbal medicines and cardiovascular drugs is prevalent in Indonesia, a country rich in ethnomedicinal diversity. However, such combinations may lead to clinically significant herb–drug interactions, potentially compromising therapeutic efficacy and safety. This narrative review aims to summarize and evaluate the pharmacokinetic and pharmacodynamic interactions between commonly used Indonesian medicinal herbs and cardiovascular agents. A comprehensive literature search was conducted using PubMed, Scopus, ScienceDirect, and Google Scholar. The included studies reported interactions involving cytochrome P450 modulation, P-glycoprotein activity, and receptor-level mechanisms. Medicinal plants such as Panax ginseng, Allium sativum, Ginkgo biloba, Glycyrrhiza glabra, Zingiber officinale, and Cassia species were found to affect drug absorption, metabolism, and bioavailability. These interactions, primarily through CYP3A4 and P-gp modulation, altered the pharmacokinetic profiles of drugs such as warfarin, digoxin, verapamil, and simvastatin. Some herbs also exert synergistic or antagonistic pharmacodynamic effects, particularly against anticoagulants and antihypertensives. Given the chronic nature of cardiovascular therapy, herb–drug interactions pose serious clinical concerns. Enhanced awareness and monitoring are essential to prevent adverse events and therapeutic failure. Further research is needed to establish safe and evidence-based integration of herbal medicines into cardiovascular care.
Downloads
References
Abebe, W. (2019). Review of Herbal Medications with The Potential to Cause Bleeding: Dental Implications, and Risk Prediction and Prevention Avenues. EPMA Journal, 10(1), 51–64. https://doi.org/10.1007/s13167-018-0158-2
Almaghrabi, M., Alghamdi, W., Alfadel, N., & Alharbi, F. (2021). Liquorice Interaction with Thiazide and Thiazide-Like Diuretics and the Potential Risk of Hypokalemia. Drug Safety: An International Journal of Medical Toxicology and Drug Experience, 44(22), 1421. Retrieved from https://www.proquest.com/openview/809a234edd2af77cb43e6182c6376809/1?pq-origsite=gscholar&cbl=32187#:~:text=However%2C consuming large amounts of,may result in severe complications.
Alshimemeri, A., Al-Mishari, H., Shoukry, E., Ali, E., & Metawe, M. (2024). A Young Adult Male with Postoperative Bleeding Following Bariatric Surgery. Critical Care & Shock, 27(3), 141. Retrieved from https://criticalcareshock.com/2024/06/12618/
Altreuther, M., Seternes, A., Saltnes, T., Myrbø, N., Vikan, K., Nilsen, L. H., & Feng, T. (2024). Antithrombotic and Lipid Lowering Therapy is Associated With Improved Survival After Vascular Surgery: A Population Based Study From Norway. European Journal of Vascular and Endovascular Surgery, 67(6), 988–994. https://doi.org/10.1016/j.ejvs.2023.10.019
Asare, F., Koffuor, G., Nyansah, W., Gyanfosu, L., & Abruquah, A. (2015). Anticoagulant and Antiplatelet Properties of The Latex of Unripe Fruits of Carica papaya L. (Caricaceae). International Journal of Basic and Clinical Pharmacology, 4(6), 1183–1188. https://doi.org/10.18203/2319-2003.ijbcp20151355
Astutik, S., Pretzsch, J., & Ndzifon Kimengsi, J. (2019). Asian Medicinal Plants’ Production and Utilization Potentials: A Review. Sustainability, 11(19), 5483. https://doi.org/10.3390/su11195483
Chaachouay, N. (2025). Synergy, Additive Effects, and Antagonism of Drugs with Plant Bioactive Compounds. Drugs and Drug Candidates, 4(1), 4. https://doi.org/10.3390/ddc4010004
Cheng, W., Xia, K., Wu, S., & Li, Y. (2023). Herb-Drug Interactions and Their Impact on Pharmacokinetics: An Update. Current Drug Metabolism, 24(1), 28–69. https://doi.org/10.2174/1389200224666230116113240
Chrubasik-Hausmann, S., Vlachojannis, J., & McLachlan, A. J. (2019). Understanding Drug Interactions with St John’s wort (Hypericum perforatum L.): Impact of Hyperforin Content. Journal of Pharmacy and Pharmacology, 71(1), 129–138. https://doi.org/10.1111/jphp.12858
Chua, Y., Ang, X., Zhong, X., & Khoo, K. (2015a). Interaction between Warfarin and Chinese Herbal Medicines. Singapore Medical Journal, 56(1), 11–18. https://doi.org/10.11622/smedj.2015004
Chua, Y., Ang, X., Zhong, X., & Khoo, K. (2015b). Interaction Between Warfarin and Chinese Herbal Medicines. Singapore Medical Journal, 56(1), 11–18. https://doi.org/10.11622/smedj.2015004
Costache, I.-I., Miron, A., Hăncianu, M., Aursulesei, V., Costache, A. D., & Aprotosoaie, A. C. (2019). Pharmacokinetic Interactions between Cardiovascular Medicines and Plant Products. Cardiovascular Therapeutics, 2019, 1–19. https://doi.org/10.1155/2019/9402781
Coumau, C., & Csajka, C. (2025). A Systematic Review and Classification of the Effects of P-glycoprotein Inhibitors and Inducers in Humans, Using Digoxin, Fexofenadine, and Dabigatran as Probe Drugs. Clinical Pharmacokinetics, 64(6), 849–863. https://doi.org/10.1007/s40262-025-01514-3
Czigle, S., Nagy, M., Mladěnka, P., & Tóth, J. (2023). Pharmacokinetic and Pharmacodynamic Herb-drug Interactions—part I. Herbal Medicines of The Central Nervous System. PeerJ, 11(e16149), 1–51. https://doi.org/10.7717/peerj.16149
Del Re, M., Roncato, R., Argentiero, A., Berrino, L., Botticelli, A., Capuano, A., … Danesi, R. (2025). Clinical Relevance and Methodological Approach for The Assessment of Drug–drug Interactions in Cancer Patients: a Position Statement from the Italian Association of Medical Oncology (AIOM) and the Italian Society of Pharmacology (SIF). ESMO Open, 10(6), 105119. https://doi.org/10.1016/j.esmoop.2025.105119
Di Minno, A., Frigerio, B., Spadarella, G., Ravani, A., Sansaro, D., Amato, M., … Baldassarre, D. (2017). Old and New Oral Anticoagulants: Food, Herbal Medicines and Drug Interactions. Blood Reviews, 31(4), 193–203. https://doi.org/10.1016/j.blre.2017.02.001
Djuv, A., & Nilsen, O. G. (2012). Aloe Vera Juice: IC50 and Dual Mechanistic Inhibition of CYP3A4 and CYP2D6. Phytotherapy Research, 26(3), 445–451. https://doi.org/10.1002/ptr.3564
Elfahmi, Woerdenbag, H. J., & Kayser, O. (2014). Jamu: Indonesian Traditional Herbal Medicine Towards Rational Phytopharmacological Use. Journal of Herbal Medicine, 4(2), 51–73. https://doi.org/10.1016/j.hermed.2014.01.002
Gamil, N. M., Elsayed, H. A., Hamed, R. M., Salah, E. T., Ahmed, A. M., Mostafa, H. A., … Abou-Hussein, D. (2025). Insights from Herb Interactions Studies: a Foundational Report for Integrative Medicine. Future Journal of Pharmaceutical Sciences, 11(46), 1–27. https://doi.org/10.1186/s43094-025-00794-7
Grimstein, M., & Huang, S.-M. (2018). A Regulatory Science Viewpoint on Botanical–drug Interactions. Journal of Food and Drug Analysis, 26(2), S12–S25. https://doi.org/10.1016/j.jfda.2018.01.013
Guengerich, F. P. (2022). Inhibition of Cytochrome P450 Enzymes by Drugs-Molecular Basis and Practical Applications. Biomolecules & Therapeutics, 30(1), 1–18. https://doi.org/10.4062/biomolther.2021.102
Hemaiswarya, S., Prabhakar, P. K., & Doble, M. (2022). Synergistic Herb Interactions with Cardiovascular Drugs. In Herb-Drug Combinations A New Complementary Therapeutic Strategy (1st ed., pp. 131–144). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-19-5125-1_9
Kansara, M. B., & Jani, A. J. (2017). Possible Interactions between Garlic and Conventional Drugs: a Review. Pharmaceutical and Biological Evaluations, 4(2), 73–81. https://doi.org/10.26510/2394-0859.pbe.2017.12
Khan, S., & Khan, S. U. (2020). Adverse Drug Event of Hypokalaemia‐induced Cardiotoxicity Secondary to The Use of Laxatives: A Systematic Review of Case Reports. Journal of Clinical Pharmacy and Therapeutics, 45(5), 927–936. https://doi.org/10.1111/jcpt.13204
Leite, P. M., Martins, M. A. P., & Castilho, R. O. (2016). Review on Mechanisms and Interactions in Concomitant Use of Herbs and Warfarin Therapy. Biomedicine & Pharmacotherapy, 83, 14–21. https://doi.org/10.1016/j.biopha.2016.06.012
Li, J., Liang, Q., & Sun, G. (2019). Interaction between Traditional Chinese Medicine and Anticoagulant/Antiplatelet Drugs. Current Drug Metabolism, 20(9), 701–713. https://doi.org/10.2174/1389200220666190827160212
Li, X., Hu, J., Wang, B., Sheng, L., Liu, Z., Yang, S., & Li, Y. (2014). Inhibitory Effects of Herbal Constituents on P-glycoprotein in Vitro and in Vivo: Herb–drug Interactions Mediated via P-gp. Toxicology and Applied Pharmacology, 275(2), 163–175. https://doi.org/10.1016/j.taap.2013.12.015
Liang, R.-J., Hsu, S.-H., Chang, T.-Y., Chiang, T.-Y., Wang, H.-J., & Ueng, Y.-F. (2022). Metabolism-involved Drug Interactions with Traditional Chinese Medicines in Cardiovascular Diseases. Journal of Food and Drug Analysis, 30(3), 331–356. https://doi.org/10.38212/2224-6614.3421
Likhodii, S., Chin, A. C., & Baskin, L. B. (2024). Role of Therapeutic Drug Monitoring to Identify Clinically Significant Drug–herbal Supplement Interaction. In A. Dasgupta (Ed.), Therapeutic Drug Monitoring (2nd ed., pp. 515–544). Elsevier. https://doi.org/10.1016/B978-0-443-18649-3.00015-X
Madaudo, C., Coppola, G., Parlati, A. L. M., & Corrado, E. (2024). Discovering Inflammation in Atherosclerosis: Insights from Pathogenic Pathways to Clinical Practice. International Journal of Molecular Sciences, 25(11), 6016. https://doi.org/10.3390/ijms25116016
Marx, W., McKavanagh, D., McCarthy, A. L., Bird, R., Ried, K., Chan, A., & Isenring, L. (2015). Correction: The Effect of Ginger (Zingiber officinale) on Platelet Aggregation: A Systematic Literature Review. PLOS ONE, 10(11), e0143675. https://doi.org/10.1371/journal.pone.0143675
Moeinipour, Z., Akaberi, M., & Sobhani, Z. (2024). Ginkgo biloba L.: An Updated Review on the Pharmacological Activities, Pharmacokinetics and Drug Interactions. Traditional and Integrative Medicine, 9(4), 442–463. https://doi.org/10.18502/tim.v9i4.17478
Moreira, D. de L., Teixeira, S. S., Monteiro, M. H. D., De-Oliveira, A. C. A. X., & Paumgartten, F. J. R. (2014). Traditional Use and Safety of Herbal Medicines. Revista Brasileira de Farmacognosia, 24(2), 248–257. https://doi.org/10.1016/j.bjp.2014.03.006
Morris, M. E., & Ren, T. (2022). Diet/Nutrient Interactions with Drug Transporters. In G. You & M. E. Morris (Eds.), Drug Transporters: Molecular Characterization and Role in Drug Disposition (3rd ed., pp. 515–541). Wiley. https://doi.org/10.1002/9781119739883.ch25
Netala, V. R., Teertam, S. K., Li, H., & Zhang, Z. (2024). A Comprehensive Review of Cardiovascular Disease Management: Cardiac Biomarkers, Imaging Modalities, Pharmacotherapy, Surgical Interventions, and Herbal Remedies. Cells, 13(17), 1471. https://doi.org/10.3390/cells13171471
Nicolussi, S., Drewe, J., Butterweck, V., & Meyer zu Schwabedissen, H. E. (2020). Clinical Relevance of St. John’s Wort Drug Interactions Revisited. British Journal of Pharmacology, 177(6), 1212–1226. https://doi.org/10.1111/bph.14936
Nyulas, K.-I., Simon-Szabó, Z., Pál, S., Fodor, M.-A., Dénes, L., Cseh, M. J., … Nemes-Nagy, E. (2024). Cardiovascular Effects of Herbal Products and Their Interaction with Antihypertensive Drugs—Comprehensive Review. International Journal of Molecular Sciences, 25(12), 6388. https://doi.org/10.3390/ijms25126388
Parveen, A., Parveen, B., Parveen, R., & Ahmad, S. (2015). Challenges and Guidelines for Clinical Trial of Herbal Drugs. Journal of Pharmacy And Bioallied Sciences, 7(4), 329. https://doi.org/10.4103/0975-7406.168035
Purwono, S., Nisa, U., Astana, P. R. W., Wijayaningsih, R. A., Wicaksono, A. J., Wahyuningsih, M. S. H., … Fakhrudin, N. (2023). Factors Affecting the Perception of Indonesian Medical Doctors on Herbal Medicine Prescription in Healthcare Facilities: Qualitative and Quantitative Studies. Journal of Herbal Medicine, 42(100747), 1–8. https://doi.org/10.1016/j.hermed.2023.100747
Qiang, T., Li, Y., Xu, X., Lin, W., & Wang, X. (2020). Effect of Herbs for Treating Coronary Heart Disease on The CYP450 Enzyme System and Transporters. American Journal of Translational Research, 12(7), 3182–3197.
Reis, A. H. (2016). On the Etiology of Cardiovascular Diseases: A New Framework for Understanding Literature Results. Medical Hypotheses, 92, 94–99. https://doi.org/10.1016/j.mehy.2016.04.046
Rombolà, L., Scuteri, D., Marilisa, S., Watanabe, C., Morrone, L. A., Bagetta, G., & Corasaniti, M. T. (2020). Pharmacokinetic Interactions between Herbal Medicines and Drugs: Their Mechanisms and Clinical Relevance. Life, 10(7), 106. https://doi.org/10.3390/life10070106
Saha, N. (2018). Clinical Pharmacokinetics and Drug Interactions. In D. Vohora & G. Singh (Eds.), Pharmaceutical Medicine and Translational Clinical Research (pp. 81–106). Elsevier. https://doi.org/10.1016/B978-0-12-802103-3.00006-7
Sakti, A. S., Nityasa, A. R., & Saputri, F. C. (2020). Effect of Uncaria gambir and Uncaria sclerophylla on Pulmonary- Thromboembolism Mice. Pharmacognosy Journal, 12(1), 192–196. https://doi.org/10.5530/pj.2020.12.29
Shadrack, K., Faraj, A., Alex, M. K., & Kenneth, N. (2019). Anti-thrombotic Effect of Zingiber officinale (Ginger) in Sprague Dawley Rats. International Journal of Research in Medical Sciences, 7(9), 3239–3245. https://doi.org/10.18203/2320-6012.ijrms20193905
Shaikh, A. S., Thomas, A. B., & Chitlange, S. S. (2020). Herb–Drug Interaction Studies of Herbs used in Treatment of Cardiovascular Disorders—A Narrative Review of Preclinical and cCinical Studies. Phytotherapy Research, 34(5), 1008–1026. https://doi.org/10.1002/ptr.6585
Shaito, A., Thuan, D. T. B., Phu, H. T., Nguyen, T. H. D., Hasan, H., Halabi, S., … Pintus, G. (2020). Herbal Medicine for Cardiovascular Diseases: Efficacy, Mechanisms, and Safety. Frontiers in Pharmacology, 11(422), 1–32. https://doi.org/10.3389/fphar.2020.00422
Shang, H., Wang, Z., Ma, H., Sun, Y., Ci, X., Gu, Y., … Si, D. (2021). Influence of Verapamil on The Pharmacokinetics of Rotundic Acid in Rats and Its Potential Mechanism. Pharmaceutical Biology, 59(1), 198–206. https://doi.org/10.1080/13880209.2021.1871634
Soleymani, S., Bahramsoltani, R., Rahimi, R., & Abdollahi, M. (2017). Clinical Risks of St John’s Wort (Hypericum perforatum) Co-administration. Expert Opinion on Drug Metabolism & Toxicology, 13(10), 1047–1062. https://doi.org/10.1080/17425255.2017.1378342
Soyata, A., Nur Hasanah, A., & Rusdiana, T. (2020). Interaction of Warfarin with Herbs Based on Pharmacokinetic and Pharmacodynamic Parameters. Indonesian Journal of Pharmaceutics, 2(2), 69–76. https://doi.org/10.24198/idjp.v2i2.27289
Sultan, S., Jahangir, A., Gussak, I. B., Kostis, J. B., Tajik, A. J., & Jahangir, A. (2017). Interactions between Supplements and Medications. In I. B. Gusak & J. B. Kostis (Eds.), Iatrogenicity Cause and Consequences of Iatrogenesis in Cardiovascular Medicine. Rutgers University Press.
Sumarya, I. M., Suarda, I. W., Sudaryati, N. L. G., & Sitepu, I. (2020). Benefits of Biopharmaca Products Towards Healthy Indonesia. Journal of Physics: Conference Series, 1469(012133), 1–8. https://doi.org/10.1088/1742-6596/1469/1/012133
Sun, D., Gao, W., Hu, H., & Zhou, S. (2022). Why 90% of clinical drug development fails and how to improve it? Acta Pharmaceutica Sinica B, 12(7), 3049–3062. https://doi.org/10.1016/j.apsb.2022.02.002
Surana, A. R., Agrawal, S. P., Kumbhare, M. R., & Gaikwad, S. B. (2021). Current Perspectives in Herbal and Conventional Drug Interactions based on Clinical Manifestations. Future Journal of Pharmaceutical Sciences, 7(103), 1–12. https://doi.org/10.1186/s43094-021-00256-w
Szallasi, A. (2023). The Vanilloid (Capsaicin) Receptor TRPV1 in Blood Pressure Regulation: A Novel Therapeutic Target in Hypertension? International Journal of Molecular Sciences, 24(10), 8769. https://doi.org/10.3390/ijms24108769
Talasaz, A. H., McGonagle, B., HajiQasemi, M., Ghelichkhan, Z. A., Sadeghipour, P., Rashedi, S., … Bikdeli, B. (2024). Pharmacokinetic and Pharmacodynamic Interactions between Food or Herbal Products and Oral Anticoagulants: Evidence Review, Practical Recommendations, and Knowledge Gaps. Seminars in Thrombosis and Hemostasis, 51(5), 560–571. https://doi.org/10.1055/s-0044-1790258
Tan, C. S. S., & Lee, S. W. H. (2021). Warfarin and Food, Herbal or Dietary Supplement Interactions: A Systematic Review. British Journal of Clinical Pharmacology, 87(2), 352–374. https://doi.org/10.1111/bcp.14404
Thikekar, A. K., Thomas, A. B., & Chitlange, S. S. (2021). Herb‐drug Interactions in Diabetes Mellitus: A Review based on Pre‐clinical and Clinical Data. Phytotherapy Research, 35(9), 4763–4781. https://doi.org/10.1002/ptr.7108
Vaou, N., Stavropoulou, E., Voidarou, C. (Chrysa), Tsakris, Z., Rozos, G., Tsigalou, C., & Bezirtzoglou, E. (2022). Interactions between Medical Plant-Derived Bioactive Compounds: Focus on Antimicrobial Combination Effects. Antibiotics, 11(8), 1014. https://doi.org/10.3390/antibiotics11081014
Wang, H., Chen, Y., Wang, L., Liu, Q., Yang, S., & Wang, C. (2023). Advancing Herbal Medicine: Enhancing Product Quality and Safety Through Robust Quality Control Practices. Frontiers in Pharmacology, 14, 1265178. https://doi.org/10.3389/fphar.2023.1265178
Zhuang, W., Liu, S., Zhao, X., Sun, N., He, T., Wang, Y., … Xi, S. (2021). Interaction Between Chinese Medicine and Warfarin: Clinical and Research Update. Frontiers in Pharmacology, 12(751107), 1–13. https://doi.org/10.3389/fphar.2021.751107
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Aditya Sindu Sakti, Gumilar Adhi Nugroho, Febrika Wediasari, Muhammad Adil Khan, Muhammad Subhan A. Sibadu (Author)
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
How to Cite
